Literature DB >> 11668187

Increased expression of tenascin-C-binding epithelial integrins in human bullous keratopathy corneas.

A V Ljubimov1, M Saghizadeh, R Pytela, D Sheppard, M C Kenney.   

Abstract

We previously found an abnormal deposition of an extracellular matrix glycoprotein, tenascin-C (TN-C), in human corneas with pseudophakic/aphakic bullous keratopathy (PBK/ABK). In this work, we studied cellular TN-C receptors in normal and PBK/ABK corneas. Cryostat sections of normal and PBK/ABK corneas were stained by immuno-fluorescence for TN-C receptors: alpha2, alpha8, alpha9, alphaVbeta3, beta1, and beta6 integrins, and annexin II. Beta6 integrin mRNA levels were assessed by semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) using beta2-microglobulin gene to normalize the samples. In PBK/ABK compared to normal corneas, relatively minor changes were observed for alpha2 and beta1 integrins, and for annexin II. Alpha8, alpha9, and beta6 subunits of TN-C receptors, alpha8beta1 alpha9beta1, and alphaVbeta6, respectively, were absent from normal central corneas but were found in the central epithelium of PBK/ABK corneas. Beta6 integrin showed the most significant accumulation. It correlated best with the expression of TN-C rather than with the expression of other alphaVbeta6 ligands, fibronectin, and vitronectin. RT-PCR analysis also showed elevated levels of beta6 mRNA in PBK/ABK compared to normal corneas. Therefore, accumulation of TN-C in PBK/ABK corneas was accompanied by an increased expression of its three binding integrins, especially alphaVbeta6 in the corneal epithelium. The interaction of tenascin-C with these integrins may contribute to the fibrotic process that occurs in PBK/ABK corneas.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11668187     DOI: 10.1177/002215540104901102

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  7 in total

1.  αVβ6 integrin promotes corneal wound healing.

Authors:  José Tomás Blanco-Mezquita; Audrey E K Hutcheon; Mary Ann Stepp; James D Zieske
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-31       Impact factor: 4.799

2.  Exfoliative epitheliopathy of bullous keratopathy with breaches in the MUC16 Glycocalyx.

Authors:  Ben J Glasgow; Oktay K Gasymov; Richard C Casey
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-06       Impact factor: 4.799

3.  The integrin needle in the stromal haystack: emerging role in corneal physiology and pathology.

Authors:  Sunil K Parapuram; William Hodge
Journal:  J Cell Commun Signal       Date:  2014-03-07       Impact factor: 5.782

4.  Tear lipocalin captures exogenous lipid from abnormal corneal surfaces.

Authors:  Ben J Glasgow; Oktay K Gasymov; Adil R Abduragimov; Jamison J Engle; Richard C Casey
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-03       Impact factor: 4.799

5.  Positively and negatively modulating cell adhesion to type I collagen via peptide grafting.

Authors:  Gary A Monteiro; Anthony V Fernandes; Harini G Sundararaghavan; David I Shreiber
Journal:  Tissue Eng Part A       Date:  2009-01-27       Impact factor: 3.845

6.  Binding of αvβ1 and αvβ6 integrins to tenascin-C induces epithelial-mesenchymal transition-like change of breast cancer cells.

Authors:  D Katoh; K Nagaharu; N Shimojo; N Hanamura; M Yamashita; Y Kozuka; K Imanaka-Yoshida; T Yoshida
Journal:  Oncogenesis       Date:  2013-08-19       Impact factor: 7.485

7.  Establishment of a 3D In Vitro Model to Accelerate the Development of Human Therapies against Corneal Diabetes.

Authors:  Shrestha Priyadarsini; Akhee Sarker-Nag; Tyler G Rowsey; Jian-Xing Ma; Dimitrios Karamichos
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.